Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Abeona Therapeutics Inc. (Nasdaq: ABEO) has successfully raised $25 million through a registered direct offering under Nasdaq rules. The funds were primarily raised to support the launch preparations for the Company's EB-101 Biologics License Application (BLA) submission and potential approval. Abeona entered into definitive agreements with existing institutional investors, issuing and selling 3..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 4.
  • textsms

Elevation Oncology Announces Pricing of $50 Million Public Offering

Elevation Oncology, a company focused on developing selective cancer therapies for solid tumors with significant unmet medical needs, has announced the pricing of an underwritten public offering of common stock and pre-funded warrants to purchase shares of common stock. The combined offering price is $2.2500 per share of common stock and accompanying warrant and $2.2499 per pre-funded warrant an..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 10.
  • textsms